SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,810.00    115.00 (1.72%)
Bid:
6,770.00
Ask:
6,775.00
Spread: 5.00 (0.074%)
Market Cap: £5.03b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Acquisition

3 Apr 2017 07:30

RNS Number : 2765B
Spirax-Sarco Engineering PLC
03 April 2017
 

 

3rd April 2017

Acquisition of Gestra for €186 million (£160 million)

Spirax-Sarco Engineering plc (Spirax Sarco), which specialises in the control and efficient use of steam, and in peristaltic pumping and associated fluid path technologies, announces that it has signed a conditional sale and purchase agreement to acquire Gestra AG and associated businesses (Gestra) from Flowserve Corporation for a cash-free, debt-free consideration of €186 million (£160 million). 

Gestra, which has its headquarters in Bremen, Germany, is a technology leader in advanced industrial boiler control systems and specialises in the design and production of valves and control systems for steam and fluid process control.

In 2016, Gestra recorded revenues of €92.5 million (£79.7 million), EBITDA of €16.6 million (£14.3 million) and EBIT of €15.2 million (£13.1 million). Approximately 80% of the company's revenues are in Europe with the balance spread roughly evenly between the Americas and Asia Pacific. 

At 31st December 2016, Gestra's gross assets were €66.8 million (£57.6 million). 

Gestra is highly complementary to the Spirax Sarco Steam Specialties business and will enhance and accelerate the implementation of Spirax Sarco's strategy for growth, as a result of its well-developed capabilities in a wide range of industries and applications.

Due to its strong brand, Gestra will be operated alongside the Spirax Sarco Steam Specialties business, targeting global growth in its key market sectors through the co-ordinated application of the knowledge and strengths of both businesses. Spirax Sarco will invest in Gestra's product and market development to extend its world-leading customer value proposition to an enlarged addressable market. 

The purchase consideration will be financed from a combination of existing cash resources and debt facilities. The acquisition will be accretive to Group earnings in 2017 but is expected to have a slightly dilutionary impact on the Group profit margin in this year.

Completion is subject to certain customary conditions, including regulatory approval of the transaction by the merger control authority in Germany. These conditions are expected to be satisfied during the current quarter. 

Nicholas Anderson, Chief Executive of Spirax-Sarco Engineering plc, said;

"We are delighted to be bringing Gestra, its management and employees into the Spirax Sarco family. Our businesses are highly complementary; Gestra will enhance the market and product offering of Spirax Sarco and will benefit from our global footprint and broader product range. We believe that this combination will deliver enhanced value to both customers and shareholders".

There will be a hosted conference call, including Q&A, for investors and analysts at 9.30am UK time today. Dial-in numbers are UK Toll Free 0808 109 0700 and for Standard International Access +44 20 3003 2666. Please use the password 'Spirax-Sarco'.

 

 

 

Enquiries:

Nicholas Anderson, Chief Executive

Kevin Boyd, Group Finance Director

Tel: 01242 535234

 

About Spirax Sarco

Spirax-Sarco Engineering plc comprises two niche businesses, Spirax Sarco for steam specialties and Watson-Marlow Fluid Technology Group for peristaltic pumps and associated fluid path technologies. The Steam Specialties business provides a broad range of fluid control products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. The Company helps its end users to improve production efficiency, reduce energy costs, water usage and emissions, improve product quality and enhance the safety of their operations. Watson-Marlow Fluid Technology Group offers the ideal solution for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance free pumps and associated technologies. The Group is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs over 5,300 people, of whom nearly 1,400 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX).

 Further information can be found at www.spiraxsarcoengineering.com

 

RNS filter: Inside information prior to release

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAELAEENXEAF
Date   Source Headline
8th Jun 20104:13 pmRNSDirector/PDMR Shareholding
4th Jun 20102:17 pmRNSHolding(s) in Company
1st Jun 20101:34 pmRNSTotal Voting Rights
28th May 20103:20 pmRNSDirector/PDMR Shareholding
25th May 20101:30 pmRNSAcquisition
21st May 20104:56 pmRNSDirector/PDMR Shareholding
14th May 20104:01 pmRNSDirector/PDMR Shareholding
14th May 201011:06 amRNSAGM Statement
11th May 20105:16 pmRNSDirector/PDMR Shareholding
11th May 20105:13 pmRNSAGM Statement
11th May 20101:00 pmRNSInterim Management Statement
4th May 201011:29 amRNSTotal Voting Rights
14th Apr 20104:04 pmRNSHolding(s) in Company
1st Apr 20109:13 amRNSTotal Voting Rights
29th Mar 20104:20 pmRNSDirector/PDMR Shareholding
29th Mar 20104:17 pmRNSHolding(s) in Company
25th Mar 201011:40 amRNSAnnual Financial Report
10th Mar 20104:21 pmRNSDirector/PDMR Shareholding
9th Mar 20105:16 pmRNSDirector/PDMR Shareholding
8th Mar 20106:15 pmRNSDirector/PDMR Shareholding
5th Mar 20104:18 pmRNSDirector/PDMR Shareholding
4th Mar 20107:00 amRNS2009 Preliminary Results
1st Mar 20106:07 pmRNSTotal Voting Rights
1st Feb 201011:13 amRNSTotal Voting Rights
1st Feb 201011:10 amRNSTotal Voting Rights - Replacement
18th Jan 20109:17 amRNSNotice of Results
8th Jan 20107:00 amRNSTrading Update
4th Jan 201010:36 amRNSTotal Voting Rights
4th Dec 20092:35 pmRNSHolding(s) in Company
1st Dec 20094:41 pmRNSDirector/PDMR Shareholding - Replacement
1st Dec 20093:58 pmRNSTotal Voting Rights
1st Dec 20093:56 pmRNSDirector/PDMR Shareholding
26th Nov 20091:49 pmRNSDirector Declaration
9th Nov 20093:42 pmRNSDirector/PDMR Shareholding
9th Nov 20097:00 amRNSInterim Management Statement
2nd Nov 20098:37 amRNSTotal Voting Rights
9th Oct 20093:21 pmRNSDirector/PDMR Shareholding
6th Oct 200912:34 pmRNSHolding(s) in Company
2nd Oct 20092:08 pmRNSHolding(s) in Company
2nd Oct 20098:30 amRNSAcquisition
1st Oct 200911:56 amRNSTotal Voting Rights
29th Sep 20094:29 pmRNSDirector/PDMR Shareholding
24th Sep 20091:49 pmRNSDirector/PDMR Shareholding
4th Sep 20092:24 pmRNSTotal Voting Rights
27th Aug 20093:32 pmRNSAcquisition
20th Aug 20097:00 amRNS2009 Half Year Results
5th Aug 20092:07 pmRNSNotice of Results
3rd Aug 20092:56 pmRNSTotal Voting Rights
16th Jul 20094:30 pmRNSDirectorate Change
2nd Jul 20093:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.